CABERMED 0.5 mg, which contains the active ingredient cabergoline, is primarily used for the treatment of certain medical conditions related to hormone imbalances.
For the indications of use of CABERMED 0.5 mg, please refer to the legal in uk CABERMED 0.5 mg page.
Common Indications
The use of CABERMED 0.5 mg is generally indicated for:
- Prolactinoma – a benign tumor of the pituitary gland that produces excess prolactin.
- Hyperprolactinemia – elevated levels of prolactin in the blood due to various causes.
- Parkinson’s disease – often indicated to manage certain symptoms in conjunction with other treatments.
- Other conditions as determined by a healthcare professional.
Mechanism of Action
CABERMED acts as a dopamine agonist, which means it stimulates dopamine receptors in the brain. This leads to a reduction in prolactin secretion, helping to manage symptoms associated with elevated levels.
Consultation with Healthcare Provider
It is important for patients to consult their healthcare provider for a proper diagnosis and to discuss the potential benefits and risks associated with CABERMED 0.5 mg usage. Adjustments to dosage and monitoring may be necessary depending on the individual’s response to the treatment.